SLC5A1 and cystic fibrosis: Third, although we provided mechanistic support on how diseases such as CF would lead to SGLT1 upregulation, it remains to be determined how SGLTi drug such as Sotagliflozin could in turn suppress ER stress responses as demonstrated in the present work.